98
6. Literatur
Abbate, E. A., C. Voitenleitner und M. R. Botchan (2006). "Structure of the papillomavirus DNA-tethering complex E2:Brd4 and a peptide that ablates HPV chromosomal association." Mol Cell 24(6): 877-889. Akira, S., H. Isshiki, T. Sugita, O. Tanabe, S. Kinoshita, Y. Nishio, T. Nakajima, T. Hirano und T. Kishimoto (1990). "A nuclear factor for IL-6 expression (NF-IL6) is a member of a C/EBP family." Embo j 9(6): 1897- 1906.
Ammermann, I., M. Bruckner, F. Matthes, T. Iftner und F. Stubenrauch (2008). "Inhibition of transcription and DNA replication by the papillomavirus E8- E2C protein is mediated by interaction with corepressor molecules." J Virol 82(11): 5127-5136.
Antson, A. A., J. E. Burns, O. V. Moroz, D. J. Scott, C. M. Sanders, I. B. Bronstein, G. G. Dodson, K. S. Wilson und N. J. Maitland (2000). "Structure of the intact transactivation domain of the human papillomavirus E2 protein." Nature 403(6771): 805-809.
Archambault, J. und T. Melendy (2013). "Targeting human papillomavirus genome replication for antiviral drug discovery." Antivir Ther 18(3): 271-283.
Arias- Pulido, H., C. L. Peyton, N. E. Joste, H. Vargas und C. M. Wheeler (2006). "Human papillomavirus type 16 integration in cervical carcinoma in situ and in invasive cervical cancer." J Clin Microbiol 44(5): 1755-1762.
Barker, N., S. Bartfeld und H. Clevers (2010). "Tissue-resident adult stem cell populations of rapidly self- renewing organs." Cell Stem Cell 7(6): 656-670.
Baxter, M. K., M. G. McPhillips, K. Ozato und A. A. McBride (2005). "The mitotic chromosome binding activity of the papillomavirus E2 protein correlates with interaction with the cellular chromosomal protein, Brd4." J Virol 79(8): 4806-4818.
Becker- Andre, M., R. Hooft van Huijsduijnen, C. Losberger, J. Whelan und J. F. Delamarter (1992). "Murine endothelial leukocyte- adhesion molecule 1 is a close structural and functional homologue of the human protein." Eur J Biochem 206(2): 401-411.
Bellanger, S., C. Demeret, S. Goyat und F. Thierry (2001). "Stability of the human papillomavirus type 18 E2 protein is regulated by a proteasome degradation pathway through its amino- terminal transactivation domain." J Virol 75(16): 7244-7251.
6. Literatur
99 Bellanger, S., C. L. Tan, W. Nei, P. P. He und F. Thierry (2010). "The human papillomavirus type 18 E2 protein is a cell cycle- dependent target of the SCFSkp2 ubiquitin ligase." J Virol 84(1): 437-444.
Bellanger, S., C. L. Tan, Y. Z. Xue, S. Teissier und F. Thierry (2011). "Tumor suppressor or oncogene? A critical role of the human papillomavirus (HPV) E2 protein in cervical cancer progression." Am J Cancer Res 1(3): 373-389.
Berg, M. und A. Stenlund (1997). "Functional interactions between papillomavirus E1 and E2 proteins." J Virol 71(5): 3853-3863.
Bernard, H. U. (2002). "Gene expression of genital human papillomaviruses and considerations on potential antiviral approaches." Antivir Ther 7(4): 219-237.
Bhattacharjee, B., N. R. Mandal, S. Roy und S. Sengupta (2008). "Characterization of sequence variations within HPV16 isolates among Indian women: prediction of causal role of rare non-synonymous variations within intact isolates in cervical cancer pathogenesis." Virology 377(1): 143-150.
Bhattacharjee, B. und S. Sengupta (2006). "CpG methylation of HPV 16 LCR at E2 binding site proximal to P97 is associated with cervical cancer in presence of intact E2." Virology 354(2): 280-285.
Bhattacharjee, B. und S. Sengupta (2006). "HPV16 E2 gene disruption and polymorphisms of E2 and LCR: some significant associations with cervical cancer in Indian women." Gynecol Oncol 100(2): 372- 378.
Blachon, S., S. Bellanger, C. Demeret und F. Thierry (2005). "Nucleo-cytoplasmic shuttling of high risk human Papillomavirus E2 proteins induces apoptosis." J Biol Chem 280(43): 36088-36098.
Blanpain, C. und E. Fuchs (2009). "Epidermal homeostasis: a balancing act of stem cells in the skin." Nat Rev Mol Cell Biol 10(3): 207-217.
Bradford, M. M. (1976). "A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein- dye binding." Analytical Biochemistry 72(1): 248-254.
Bromberg- White, J. L. und C. Meyers (2003). "Comparison of the basal and glucocorticoid-inducible activities of the upstream regulatory regions of HPV18 and HPV31 in multiple epithelial cell lines." Virology 306(2): 197-202.
Bromberg- White, J. L., E. Sen, S. Alam, J. M. Bodily und C. Meyers (2003). "Induction of the upstream regulatory region of human papillomavirus type 31 by dexamethasone is differentiation dependent." J Virol 77(20): 10975-10983.
6. Literatur
100 Bruggemeier, U., M. Kalff, S. Franke, C. Scheidereit und M. Beato (1991). "Ubiquitous transcription factor OTF- 1 mediates induction of the MMTV promoter through synergistic interaction with hormone receptors." Cell 64(3): 565-572.
Burnette, W. N. (1981). "“Western Blotting”: Electrophoretic transfer of proteins from sodium dodecyl sulfate- polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A." Analytical Biochemistry 112(2): 195-203.
Carson, A. und S. A. Khan (2006). "Characterization of transcription factor binding to human papillomavirus type 16 DNA during cellular differentiation." J Virol 80(9): 4356-4362.
Cawley, S., S. Bekiranov, H. H. Ng, P. Kapranov, E. A. Sekinger, D. Kampa, A. Piccolboni, V. Sementchenko, J. Cheng, A. J. Williams, R. Wheeler, B. Wong, J. Drenkow, M. Yamanaka, S. Patel, S. Brubaker, H. Tammana, G. Helt, K. Struhl und T. R. Gingeras (2004). "Unbiased mapping of transcription factor binding sites along human chromosomes 21 and 22 points to widespread regulation of noncoding RNAs." Cell 116(4): 499-509.
Chaiwongkot, A., S. Vinokurova, C. Pientong, T. Ekalaksananan, B. Kongyingyoes, P. Kleebkaow, B. Chumworathayi, N. Patarapadungkit, M. Reuschenbach und M. von Knebel Doeberitz (2013). "Differential methylation of E2 binding sites in episomal and integrated HPV 16 genomes in preinvasive and invasive cervical lesions." Int J Cancer 132(9): 2087-2094.
Chang, S. W., W. C. Liu, K. Y. Liao, Y. P. Tsao, P. H. Hsu und S. L. Chen (2014). "Phosphorylation of HPV-16 E2 at serine 243 enables binding to Brd4 and mitotic chromosomes." PLoS One 9(10): e110882. Chiang, C. M., T. R. Broker und L. T. Chow (1991). "An E1M-- E2C fusion protein encoded by human papillomavirus type 11 is asequence-specific transcription repressor." J Virol 65(6): 3317-3329.
Chiang, C. M., G. Dong, T. R. Broker und L. T. Chow (1992). "Control of human papillomavirus type 11 origin of replication by the E2 family of transcription regulatory proteins." J Virol 66(9): 5224-5231.
Chong, T., W. K. Chan und H. U. Bernard (1990). "Transcriptional activation of human papillomavirus 16 by nuclear factor I, AP1, steroid receptors and a possibly novel transcription factor, PVF: a model for the composition of genital papillomavirus enhancers." Nucleic Acids Res 18(3): 465-470.
Clower, R. V., J. C. Fisk und T. Melendy (2006). "Papillomavirus E1 protein binds to and stimulates human topoisomerase I." J Virol 80(3): 1584-1587.
Clower, R. V., Y. Hu und T. Melendy (2006). "Papillomavirus E2 protein interacts with and stimulates human topoisomerase I." Virology 348(1): 13-18.
6. Literatur
101 Conrad, M., V. J. Bubb und R. Schlegel (1993). "The human papillomavirus type 6 and 16 E5 proteins are membrane-associated proteins which associate with the 16- kilodalton pore- forming protein." J Virol 67(10): 6170-6178.
Conway, M. J. und C. Meyers (2009). "Replication and assembly of human papillomaviruses." J Dent Res 88(4): 307-317.
Crow, J. M. (2012). "HPV: The global burden." Nature 488(7413): S2-3.
Culp, T. D., L. R. Budgeon, M. P. Marinkovich, G. Meneguzzi und N. D. Christensen (2006). "Keratinocyte- secreted laminin 5 can function as a transient receptor for human papillomaviruses by binding virions and transferring them to adjacent cells." J Virol 80(18): 8940-8950.
Daniel, B., A. Rangarajan, G. Mukherjee, E. Vallikad und S. Krishna (1997). "The link between integration and expression of human papillomavirus type 16 genomes and cellular changes in the evolution of cervical intraepithelial neoplastic lesions." J Gen Virol 78 ( Pt 5): 1095-1101.
Das, D., B. Bhattacharjee, S. Sen, I. Mukhopadhyay und S. Sengupta (2010). "Association of viral load with HPV16 positive cervical cancer pathogenesis: causal relevance in isolates harboring intact viral E2 gene." Virology 402(1): 197-202.
De Villiers, E. M., C. Fauquet, T. R. Broker, H. U. Bernard und H. zur Hausen (2004). "Classification of papillomaviruses." Virology 324(1): 17-27.
Demeret, C., C. Desaintes, M. Yaniv und F. Thierry (1997). "Different mechanisms contribute to the E2- mediated transcriptional repression of human papillomavirus type 18 viral oncogenes." J Virol 71(12): 9343-9349.
Demeret, C., A. Garcia- Carranca und F. Thierry (2003). "Transcription- independent triggering of the extrinsic pathway of apoptosis by human papillomavirus 18 E2 protein." Oncogene 22(2): 168-175.
Descombes, P. und U. Schibler (1991). "A liver- enriched transcriptional activator protein, LAP, and a transcriptional inhibitory protein, LIP, are translated from the same mRNA." Cell 67(3): 569-579.
Dey, A., F. Chitsaz, A. Abbasi, T. Misteli und K. Ozato (2003). "The double bromodomain protein Brd4 binds to acetylated chromatin during interphase and mitosis." Proc Natl Acad Sci U S A 100(15): 8758- 8763.
Dianova (2005). Immunologie: Fluoreszenz Topics: Ein Handbuch für die Immunfluoreszenz.
DiLorenzo, T. P., D. Chen, P. Zhang und B. M. Steinberg (1998). "Evidence for the separate regulation of the human papillomavirus type 11 E7 and E6 promoters by Viral cis sequences near the E6 promoter." Virology 243(1): 130-139.
6. Literatur
102 Ding, D. C., M. H. Chiang, H. C. Lai, C. A. Hsiung, C. Y. Hsieh und T. Y. Chu (2009). "Methylation of the long control region of HPV16 is related to the severity of cervical neoplasia." Eur J Obstet Gynecol Reprod Biol 147(2): 215-220.
Dixon, E. P., G. L. Pahel, W. J. Rocque, J. A. Barnes, D. C. Lobe, M. H. Hanlon, K. A. Alexander, S. F. Chao, K. Lindley und W. C. Phelps (2000). "The E1 helicase of human papillomavirus type 11 binds to the origin of replication with low sequence specificity." Virology 270(2): 345-357.
Dong, G., T. R. Broker und L. T. Chow (1994). "Human papillomavirus type 11 E2 proteins repress the homologous E6 promoter by interfering with the binding of host transcription factors to adjacent elements." J Virol 68(2): 1115-1127.
Doorbar, J. (2006). "Molecular biology of human papillomavirus infection and cervical cancer." Clin Sci (Lond) 110(5): 525-541.
Dreer, M., S. van de Poel und F. Stubenrauch (2016). "Control of viral replication and transcription by the papillomavirus E8^E2 protein." Virus Res.
Duwe (2009). Der Einfluss des viralen E2 Proteins auf die Regulation der Expression des humanen Papillomavirus Typ 11 (HPV 11) in transgenen Mäusen Bachelor Ruprecht Karls University Heidelberg. Ferguson, R. E., H. P. Carroll, A. Harris, E. R. Maher, P. J. Selby und R. E. Banks (2005). "Housekeeping proteins: a preliminary study illustrating some limitations as useful references in protein expression studies." Proteomics 5(2): 566-571.
Foresta, C., A. Ferlin, A. Bertoldo, C. Patassini, D. Zuccarello und A. Garolla (2011). "Human papilloma virus in the sperm cryobank: an emerging problem?" Int J Androl 34(3): 242-246.
Fradet- Turcotte, A., F. Bergeron- Labrecque, C. A. Moody, M. Lehoux, L. A. Laimins und J. Archambault (2011). "Nuclear accumulation of the papillomavirus E1 helicase blocks S-phase progression and triggers an ATM-dependent DNA damage response." J Virol 85(17): 8996-9012.
Frattini, M. G. und L. A. Laimins (1994). "Binding of the human papillomavirus E1 origin- recognition protein is regulated through complex formation with the E2 enhancer- binding protein." Proc Natl Acad Sci U S A 91(26): 12398-12402.
Freitas, A. C., F. C. Mariz, M. A. Silva und A. L. Jesus (2013). "Human papillomavirus vertical transmission: review of current data." Clin Infect Dis 56(10): 1451-1456.
Gagnon, D., S. Joubert, H. Senechal, A. Fradet-Turcotte, S. Torre und J. Archambault (2009). "Proteasomal degradation of the papillomavirus E2 protein is inhibited by overexpression of bromodomain-containing protein 4." J Virol 83(9): 4127-4139.
6. Literatur
103 Garcia-Carranca, A., F. Thierry und M. Yaniv (1988). "Interplay of viral and cellular proteins along the long control region of human papillomavirus type 18." J Virol 62(11): 4321-4330.
Garcia- Vallve, S., A. Alonso und I. G. Bravo (2005). "Papillomaviruses: different genes have different histories." Trends Microbiol 13(11): 514-521.
Genther Williams, S. M., G. L. Disbrow, R. Schlegel, D. Lee, D. W. Threadgill und P. F. Lambert (2005). "Requirement of epidermal growth factor receptor for hyperplasia induced by E5, a high-risk human papillomavirus oncogene." Cancer Res 65(15): 6534-6542.
Giannakouros, T., E. Nikolakaki, I. Mylonis und E. Georgatsou (2011). "Serine-arginine protein kinases: a small protein kinase family with a large cellular presence." Febs j 278(4): 570-586.
Gillespie, K. A., K. P. Mehta, L. A. Laimins und C. A. Moody (2012). "Human papillomaviruses recruit cellular DNA repair and homologous recombination factors to viral replication centers." J Virol 86(17): 9520-9526.
Giovannelli, L., M. C. Migliore, G. Capra, M. P. Caleca, C. Bellavia, A. Perino, E. Viviano, D. Matranga und P. Ammatuna (2007). "Penile, urethral, and seminal sampling for diagnosis of human papillomavirus infection in men." J Clin Microbiol 45(1): 248-251.
Giri, I. und M. Yaniv (1988). "Structural and mutational analysis of E2 trans-activating proteins of papillomaviruses reveals three distinct functional domains." Embo j 7(9): 2823-2829.
Gissmann, L., V. Diehl, H. J. Schultz- Coulon und H. zur Hausen (1982). "Molecular cloning and characterization of human papilloma virus DNA derived from a laryngeal papilloma." J Virol 44(1): 393- 400.
Gloss, B. und H. U. Bernard (1990). "The E6/ E7 promoter of human papillomavirus type 16 is activated in the absence of E2 proteins by a sequence-aberrant Sp1 distal element." J Virol 64(11): 5577-5584. Gloss, B., H. U. Bernard, K. Seedorf und G. Klock (1987). "The upstream regulatory region of the human papilloma virus- 16 contains an E2 protein-independent enhancer which is specific for cervical carcinoma cells and regulated by glucocorticoid hormones." Embo j 6(12): 3735-3743.
Goodwin, E. C. und D. DiMaio (2000). "Repression of human papillomavirus oncogenes in HeLa cervical carcinoma cells causes the orderly reactivation of dormant tumor suppressor pathways." Proc Natl Acad Sci U S A 97(23): 12513-12518.
Hallmann, R., D. N. Mayer, E. L. Berg, R. Broermann und E. C. Butcher (1995). "Novel mouse endothelial cell surface marker is suppressed during differentiation of the blood brain barrier." Dev Dyn 202(4): 325- 332.
6. Literatur
104 Han, B., E. A. Rorke, G. Adhikary, Y. C. Chew, W. Xu und R. L. Eckert (2012). "Suppression of AP1 transcription factor function in keratinocyte suppresses differentiation." PLoS One 7(5): e36941.
Harwood, C. A. und C. M. Proby (2002). "Human papillomaviruses and non- melanoma skin cancer." Curr Opin Infect Dis 15(2): 101-114.
Hegde, R. S., S. R. Grossman, L. A. Laimins und P. B. Sigler (1992). "Crystal structure at 1.7 A of the bovine papillomavirus- 1 E2 DNA-binding domain bound to its DNA target." Nature 359(6395): 505-512. Helt, A. M. und D. A. Galloway (2001). "Destabilization of the retinoblastoma tumor suppressor by human papillomavirus type 16 E7 is not sufficient to overcome cell cycle arrest in human keratinocytes." J Virol 75(15): 6737-6747.
Hernandez- Ramon, E. E., J. E. Burns, W. Zhang, H. F. Walker, S. Allen, A. A. Antson und N. J. Maitland (2008). "Dimerization of the human papillomavirus type 16 E2 N terminus results in DNA looping within the upstream regulatory region." J Virol 82(10): 4853-4861.
Houzelstein, D., S. L. Bullock, D. E. Lynch, E. F. Grigorieva, V. A. Wilson und R. S. Beddington (2002). "Growth and early postimplantation defects in mice deficient for the bromodomain-containing protein Brd4." Mol Cell Biol 22(11): 3794-3802.
Howley, P. M., K. Munger, B. A. Werness, W. C. Phelps und R. Schlegel (1989). "Molecular mechanisms of transformation by the human papillomaviruses." Princess Takamatsu Symp 20: 199-206.
Huang, C., W. Y. Ma, D. Hanenberger, M. P. Cleary, G. T. Bowden und Z. Dong (1997). "Inhibition of ultraviolet B-induced activator protein-1 (AP-1) activity by aspirin in AP- 1- luciferase transgenic mice." J Biol Chem 272(42): 26325-26331.
Huibregtse, J. M., M. Scheffner und P. M. Howley (1991). "A cellular protein mediates association of p53 with the E6 oncoprotein of human papillomavirus types 16 or 18." Embo j 10(13): 4129-4135.
Iftner, T., J. Haedicke-Jarboui, S. Y. Wu und C. M. Chiang (2016). "Involvement of Brd4 in different steps of the papillomavirus life cycle." Virus Res.
Jaks, V., M. Kasper und R. Toftgard (2010). "The hair follicle- a stem cell zoo." Exp Cell Res 316(8): 1422- 1428.
Jiaping Xue, B. J. V. und James A. Radosevich (2012). Human Papillomavirus: A Brief Overview.
Johannsen, E. und P. F. Lambert (2013). "Epigenetics of human papillomaviruses." Virology 445(1-2): 205-212.
Jones, D. L., D. A. Thompson und K. Munger (1997). "Destabilization of the RB tumor suppressor protein and stabilization of p53 contribute to HPV type 16 E7-induced apoptosis." Virology 239(1): 97-107.
6. Literatur
105 Kabsch, K. und A. Alonso (2002). "The human papillomavirus type 16 E5 protein impairs TRAIL- and FasL- mediated apoptosis in HaCaT cells by different mechanisms." J Virol 76(23): 12162-12172.
Kaczkowski, B., M. Rossing, D. K. Andersen, A. Dreher, M. Morevati, M. A. Visser, O. Winther, F. C. Nielsen und B. Norrild (2012). "Integrative analyses reveal novel strategies in HPV11, -16 and -45 early infection." Sci Rep 2: 515.
Kalantari, M., E. Blennow, B. Hagmar und B. Johansson (2001). "Physical state of HPV16 and chromosomal mapping of the integrated form in cervical carcinomas." Diagn Mol Pathol 10(1): 46-54. Kessis, T. D., R. J. Slebos, W. G. Nelson, M. B. Kastan, B. S. Plunkett, S. M. Han, A. T. Lorincz, L. Hedrick und K. R. Cho (1993). "Human papillomavirus 16 E6 expression disrupts the p53- mediated cellular response to DNA damage." Proc Natl Acad Sci U S A 90(9): 3988-3992.
Kim, K., P. A. Garner- Hamrick, C. Fisher, D. Lee und P. F. Lambert (2003). "Methylation patterns of papillomavirus DNA, its influence on E2 function, and implications in viral infection." J Virol 77(23): 12450- 12459.
Kivi, N., D. Greco, P. Auvinen und E. Auvinen (2008). "Genes involved in cell adhesion, cell motility and mitogenic signaling are altered due to HPV 16 E5 protein expression." Oncogene 27(18): 2532-2541. Klock, G., B. Gloss und H. U. Bernard (1988). "Constitutive and steroid hormone regulated transcriptional enhancer elements in the genome of the human papilloma virus type 16, which is associated with neoplasia of the cervix." Cancer Detect Prev 12(1-6): 23-29.
Knight, J. D., R. Li und M. Botchan (1991). "The activation domain of the bovine papillomavirus E2 protein mediates association of DNA-bound dimers to form DNA loops." Proc Natl Acad Sci U S A 88(8): 3204- 3208.
Kyo, S., M. Inoue, Y. Nishio, K. Nakanishi, S. Akira, H. Inoue, M. Yutsudo, O. Tanizawa und A. Hakura (1993). "NF- IL6 represses early gene expression of human papillomavirus type 16 through binding to the noncoding region." J Virol 67(2): 1058-1066.
Kyo, S., A. Tam und L. A. Laimins (1995). "Transcriptional activity of human papillomavirus type 31b enhancer is regulated through synergistic interaction of AP1 with two novel cellular factors." Virology 211(1): 184-197.
Lai, Y. M., F. P. Yang und C. C. Pao (1996). "Human papillomavirus deoxyribonucleic acid and ribonucleic acid in seminal plasma and sperm cells." Fertil Steril 65(5): 1026-1030.
Lambert, P. F., B. A. Spalholz und P. M. Howley (1987). "A transcriptional repressor encoded by BPV-1 shares a common carboxy-terminal domain with the E2 transactivator." Cell 50(1): 69-78.
6. Literatur
106 Lechner, M. S. und L. A. Laimins (1994). "Inhibition of p53 DNA binding by human papillomavirus E6 proteins." J Virol 68(7): 4262-4273.
Lee, A. Y. und C. M. Chiang (2009). "Chromatin adaptor Brd4 modulates E2 transcription activity and protein stability." J Biol Chem 284(5): 2778-2786.
Lee, P., D. J. Lee, C. Chan, S. W. Chen, I. Ch'en und C. Jamora (2009). "Dynamic expression of epidermal caspase 8 simulates a wound healing response." Nature 458(7237): 519-523.
Lehoux, M., D. Gagnon und J. Archambault (2014). "E1- mediated recruitment of a UAF1- USP deubiquitinase complex facilitates human papillomavirus DNA replication." J Virol 88(15): 8545-8555. Leykauf, K., K. Kabsch, N. Gassler, L. Gissmann, A. Alonso und J. Schenkel (2008). "Expression of the HPV11 E2 gene in transgenic mice does not result in alterations of the phenotypic pattern." Transgenic Res 17(1): 1-8.
Lillsunde Larsson, G., G. Helenius, B. Sorbe und M. G. Karlsson (2014). "Viral Load, Integration and Methylation of E2BS3 and 4 in Human Papilloma Virus (HPV) 16- Positive Vaginal and Vulvar Carcinomas." PLoS One 9(11): e112839.
Lim, D. A., M. Gossen, C. W. Lehman und M. R. Botchan (1998). "Competition for DNA binding sites between the short and long forms of E2 dimers underlies repression in bovine papillomavirus type 1 DNA replication control." J Virol 72(3): 1931-1940.
Lin, J. Y. und D. E. Fisher (2007). "Melanocyte biology and skin pigmentation." Nature 445(7130): 843- 850.
Liu, J. S., S. R. Kuo, T. R. Broker und L. T. Chow (1995). "The functions of human papillomavirus type 11 E1, E2, and E2C proteins in cell-free DNA replication." J Biol Chem 270(45): 27283-27291.
Loo, Y. M. und T. Melendy (2004). "Recruitment of replication protein A by the papillomavirus E1 protein and modulation by single-stranded DNA." J Virol 78(4): 1605-1615.
Lu, J. Z., Y. N. Sun, R. C. Rose, W. Bonnez und D. J. McCance (1993). "Two E2 binding sites (E2BS) alone or one E2BS plus an A/T-rich region are minimal requirements for the replication of the human papillomavirus type 11 origin." J Virol 67(12): 7131-7139.
Maitland, N. J., S. Conway, N. S. Wilkinson, J. Ramsdale, J. R. Morris, C. M. Sanders, J. E. Burns, P. L. Stern und M. Wells (1998). "Expression patterns of the human papillomavirus type 16 transcription factor E2 in low- and high- grade cervical intraepithelial neoplasia." J Pathol 186(3): 275-280.
Mazumder Indra, D., R. K. Singh, S. Mitra, S. Dutta, C. Chakraborty, P. S. Basu, R. K. Mondal, S. Roychoudhury und C. K. Panda (2011). "Genetic and epigenetic changes of HPV16 in cervical cancer
6. Literatur
107 differentially regulate E6/ E7 expression and associate with disease progression." Gynecol Oncol 123(3): 597-604.
McBride, A. A. (2013). "The papillomavirus E2 proteins." Virology 445(1-2): 57-79.
McBride, A. A., J. C. Byrne und P. M. Howley (1989). "E2 polypeptides encoded by bovine papillomavirus type 1 form dimers through the common carboxyl- terminal domain: transactivation is mediated by the conserved amino- terminal domain." Proc Natl Acad Sci U S A 86(2): 510-514.
McPhillips, M. G., J. G. Oliveira, J. E. Spindler, R. Mitra und A. A. McBride (2006). "Brd4 is required for e2- mediated transcriptional activation but not genome partitioning of all papillomaviruses." J Virol 80(19): 9530-9543.
Melendy, T., J. Sedman und A. Stenlund (1995). "Cellular factors required for papillomavirus DNA replication." J Virol 69(12): 7857-7867.
Miller, S. J., T. T. Sun und R. M. Lavker (1993). "Hair follicles, stem cells, and skin cancer." J Invest Dermatol 100(3): 288s-294s.
Mittal, R., A. Pater und M. M. Pater (1993). "Multiple human papillomavirus type 16 glucocorticoid response elements functional for transformation, transient expression, and DNA- protein interactions." J Virol 67(9): 5656-5659.
Molijn, A., B. Kleter, W. Quint und L. J. van Doorn (2005). "Molecular diagnosis of human papillomavirus (HPV) infections." J Clin Virol 32 Suppl 1: S43-51.
Moody, C. A. und L. A. Laimins (2009). "Human papillomaviruses activate the ATM DNA damage pathway for viral genome amplification upon differentiation." PLoS Pathog 5(10): e1000605.
Munoz, N., F. X. Bosch, S. de Sanjose, R. Herrero, X. Castellsague, K. V. Shah, P. J. Snijders und C. J. Meijer (2003). "Epidemiologic classification of human papillomavirus types associated with cervical cancer." N Engl J Med 348(6): 518-527.
Munoz, N., X. Castellsague, A. B. de Gonzalez und L. Gissmann (2006). "Chapter 1: HPV in the etiology of human cancer." Vaccine 24 Suppl 3: S3/1-10.
Nelson, L. M., R. C. Rose, L. LeRoux, C. Lane, K. Bruya und J. Moroianu (2000). "Nuclear import and DNA binding of human papillomavirus type 45 L1 capsid protein." J Cell Biochem 79(2): 225-238.
Nelson, L. M., R. C. Rose und J. Moroianu (2002). "Nuclear import strategies of high risk HPV16 L1 major capsid protein." J Biol Chem 277(26): 23958-23964.
6. Literatur
108 Nishimura, A., T. Ono, A. Ishimoto, J. J. Dowhanick, M. A. Frizzell, P. M. Howley und H. Sakai (2000). "Mechanisms of human papillomavirus E2-mediated repression of viral oncogene expression and cervical cancer cell growth inhibition." J Virol 74(8): 3752-3760.
O'Connor, M. J., W. Stunkel, C. H. Koh, H. Zimmermann und H. U. Bernard (2000). "The differentiation- specific factor CDP/Cut represses transcription and replication of human papillomaviruses through a conserved silencing element." J Virol 74(1): 401-410.
Oliveira, J. G., L. A. Colf und A. A. McBride (2006). "Variations in the association of papillomavirus E2 proteins with mitotic chromosomes." Proc Natl Acad Sci U S A 103(4): 1047-1052.
Opazo, F. (2014). Probing Biological Samples in High-Resolution Microscopy: Making Sense of Spots. T Super-Resolution Microscopy Techniques in the Neuroscience. 86: 369-386.
Oshima, H., A. Rochat, C. Kedzia, K. Kobayashi und Y. Barrandon (2001). "Morphogenesis and renewal of hair follicles from adult multipotent stem cells." Cell 104(2): 233-245.
Paddock, S. W. (2000). "Principles and practices of laser scanning confocal microscopy." Mol Biotechnol 16(2): 127-149.
Parfenov, M., C. S. Pedamallu, N. Gehlenborg, S. S. Freeman, L. Danilova, C. A. Bristow, S. Lee, A. G. Hadjipanayis, E. V. Ivanova, M. D. Wilkerson, A. Protopopov, L. Yang, S. Seth, X. Song, J. Tang, X. Ren, J. Zhang, A. Pantazi, N. Santoso, A. W. Xu, H. Mahadeshwar, D. A. Wheeler, R. I. Haddad, J. Jung, A. I. Ojesina, N. Issaeva, W. G. Yarbrough, D. N. Hayes, J. R. Grandis, A. K. El-Naggar, M. Meyerson, P. J. Park, L. Chin, J. G. Seidman, P. S. Hammerman und R. Kucherlapati (2014). "Characterization of HPV and host genome interactions in primary head and neck cancers." Proc Natl Acad Sci U S A.
Parish, J. L., A. Kowalczyk, H. T. Chen, G. E. Roeder, R. Sessions, M. Buckle und K. Gaston (2006). "E2 proteins from high- and low- risk human papillomavirus types differ in their ability to bind p53 and induce apoptotic cell death." J Virol 80(9): 4580-4590.
Park, J. S. und S. Hur (2013). "Up to date: comprehensive knowledge of human papillomavirus." Expert Rev Vaccines 12(4): 353-355.
Passegue, E., W. Jochum, M. Schorpp- Kistner, U. Mohle- Steinlein und E. F. Wagner (2001). "Chronic myeloid leukemia with increased granulocyte progenitors in mice lacking junB expression in the myeloid lineage." Cell 104(1): 21-32.
Paus, R. und G. Cotsarelis (1999). "The biology of hair follicles." N Engl J Med 341(7): 491-497.
Pfefferle, R., G. P. Marcuzzi, B. Akgul, H. U. Kasper, F. Schulze, I. Haase, C. Wickenhauser und H. Pfister (2008). "The human papillomavirus type 8 E2 protein induces skin tumors in transgenic mice." J Invest Dermatol 128(9): 2310-2315.
6. Literatur
109 Prescott, E. L., C. L. Brimacombe, M. Hartley, I. Bell, S. Graham und S. Roberts (2014). "Human papillomavirus type 1 E1^E4 protein is a potent inhibitor of the serine-arginine (SR) protein kinase SRPK1 and inhibits phosphorylation of host SR proteins and of the viral transcription and replication regulator E2." J Virol 88(21): 12599-12611.
Protopapa, E. E., H. Gaissert, A. Xenakis, S. Avramiotis, N. Stavrianeas, C. E. Sekeris, J. Schenkel und A. Alonso (1999). "The effect of proteolytic enzymes on hair follicles of transgenic mice expressing the lac Z-protein in cells of the bulge region." J Eur Acad Dermatol Venereol 13(1): 28-35.
Ralph, W. M., Jr., K. Liu und K. J. Auborn (2006). "CCAAT/enhancer- binding protein beta represses human papillomavirus 11 upstream regulatory region expression through a promoter-proximal YY1- binding site." J Gen Virol 87(Pt 1): 51-59.
Reinson, T., M. Toots, M. Kadaja, R. Pipitch, M. Allik, E. Ustav und M. Ustav (2013). "Engagement of the ATR-dependent DNA damage response at the human papillomavirus 18 replication centers during the initial amplification." J Virol 87(2): 951-964.
Roberts, S., I. Ashmole, L. J. Gibson, S. M. Rookes, G. J. Barton und P. H. Gallimore (1994). "Mutational analysis of human papillomavirus E4 proteins: identification of structural features important in the formation of cytoplasmic E4/cytokeratin networks in epithelial cells." J Virol 68(10): 6432-6445.
Robinson, G. W., P. F. Johnson, L. Hennighausen und E. Sterneck (1998). "The C/EBPbeta transcription factor regulates epithelial cell proliferation and differentiation in the mammary gland." Genes Dev 12(12): 1907-1916.
Romanczuk, H., F. Thierry und P. M. Howley (1990). "Mutational analysis of cis elements involved in E2 modulation of human papillomavirus type 16 P97 and type 18 P105 promoters." J Virol 64(6): 2849-2859. Sakakibara, N., R. Mitra und A. A. McBride (2011). "The papillomavirus E1 helicase activates a cellular DNA damage response in viral replication foci." J Virol 85(17): 8981-8995.
Sanders, C. M. und N. J. Maitland (1994). "Kinetic and equilibrium binding studies of the human papillomavirus type- 16 transcription regulatory protein E2 interacting with core enhancer elements."